Icahn Enterprises L.P. IEP
6.96
0.01
0.14%
as of 25 Sep
- Market cap
- $4.9B
- P/E
- 0.0×
Follow IEP
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.45 | 0.48 | 0.44 | 0.51 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
41.58 | 12.11 | (10.08) | 322.77 | |
P/B ratio |
2.25 | 2.05 | 1.24 | 1.42 | |
Price to Tangible BV |
3.16 | 2.80 | 1.52 | 1.75 | |
EV/Sales |
0.62 | 0.63 | 0.54 | 0.57 | |
EV/EBITDA |
9.15 | 7.21 | 6.13 | 9.04 | |
EV/Operating CF |
60.96 | 23.57 | (16.58) | 15.53 | |
EV/FCF |
(25.99) | (24.59) | (6.10) | (26.67) | |
Quick Ratio |
2.81 | 2.61 | 4.10 | 4.18 | |
Current Ratio |
2.87 | 2.67 | 4.17 | 4.24 | |
Net Debt/EBITDA |
(12.68) | (4.04) | 2.50 | 0.75 | |
Debt/Assets |
49.57% | 49.42% | 46.54% | 45.11% | |
Debt/Equity |
2.98 | 2.72 | 1.93 | 1.96 | |
Asset Turnover |
0.76 | 0.70 | 0.63 | 0.59 | |
Operating CF/Net income |
(0.33) | (0.88) | (210.50) | 0.05 | |
Capex/Depreciation |
(0.65) | (0.93) | (0.39) | (0.55) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.82% | 9.47% | 7.82% | 8.00% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.05 | 0.04 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.89) | (0.85) | (0.69) | (0.64) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(10.26%) | (6.89%) | (7.95%) | (9.38%) | |
Free Cash Flow Yield |
(5.20%) | (5.30%) | (20.06%) | (4.23%) | |
Revenue per Share |
4.45 | 3.46 | 4.80 | 4.74 | |
Operating CF per Share |
0.17 | 0.62 | (0.75) | 0.03 | |
Capex per Share |
(0.12) | (0.18) | (0.14) | (0.15) | |
Free Cash Flow per Share |
0.05 | 0.44 | (0.88) | (0.13) | |
Cash per Share |
7.01 | 7.74 | 10.09 | 10.54 | |
Shareholders Equity per Share |
3.21 | 3.68 | 6.10 | 5.95 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.21 | 3.68 | 6.10 | 5.95 | |
Free Cash Flow |
35.00 | 283.00 | (497.00) | (72.00) | |
Working Capital |
4,200.00 | 4,055.00 | 5,966.00 | 6,363.00 | |
Capital Expenditures |
(81.00) | (114.00) | (76.00) | (87.00) | |
Net Current Asset Value |
(4,299.00) | (4,096.00) | (2,941.00) | (3,079.00) | |
EV/EBIT |
57.72 | 24.02 | 21.27 | 80.40 | |
Capex to Sales |
0.03 | 0.05 | 0.03 | 0.03 | |
Net Profit Margin |
(11.70%) | (20.40%) | 0.07% | 10.31% | |
Price to Operating Income |
42.69 | 18.43 | 17.39 | 71.20 | |
| Other line items | |||||
Average Receivables |
1,650.00 | 1,524.00 | 2,076.00 | 2,797.00 | |
Average Payables |
705.50 | 813.50 | 746.00 | 676.00 | |
Average Assets |
13,864.50 | 14,207.00 | 15,247.00 | 16,134.50 | |
Average Common Equity |
2,784.50 | 3,044.50 | 4,023.50 | 4,123.00 |
Columns are period end dates